1. Home
  2. BLFS vs CRI Comparison

BLFS vs CRI Comparison

Compare BLFS & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • CRI
  • Stock Information
  • Founded
  • BLFS 1987
  • CRI 1865
  • Country
  • BLFS United States
  • CRI United States
  • Employees
  • BLFS N/A
  • CRI N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • CRI Apparel
  • Sector
  • BLFS Health Care
  • CRI Consumer Discretionary
  • Exchange
  • BLFS Nasdaq
  • CRI Nasdaq
  • Market Cap
  • BLFS 1.2B
  • CRI 1.3B
  • IPO Year
  • BLFS 1989
  • CRI 2003
  • Fundamental
  • Price
  • BLFS $23.29
  • CRI $34.14
  • Analyst Decision
  • BLFS Strong Buy
  • CRI Sell
  • Analyst Count
  • BLFS 7
  • CRI 5
  • Target Price
  • BLFS $30.57
  • CRI $36.20
  • AVG Volume (30 Days)
  • BLFS 573.8K
  • CRI 1.6M
  • Earning Date
  • BLFS 05-08-2025
  • CRI 04-25-2025
  • Dividend Yield
  • BLFS N/A
  • CRI 9.38%
  • EPS Growth
  • BLFS N/A
  • CRI N/A
  • EPS
  • BLFS N/A
  • CRI 4.51
  • Revenue
  • BLFS $87,762,000.00
  • CRI $2,812,437,000.00
  • Revenue This Year
  • BLFS $20.32
  • CRI N/A
  • Revenue Next Year
  • BLFS $19.98
  • CRI N/A
  • P/E Ratio
  • BLFS N/A
  • CRI $7.56
  • Revenue Growth
  • BLFS N/A
  • CRI N/A
  • 52 Week Low
  • BLFS $17.15
  • CRI $32.04
  • 52 Week High
  • BLFS $29.55
  • CRI $72.11
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 49.30
  • CRI 44.12
  • Support Level
  • BLFS $21.13
  • CRI $32.42
  • Resistance Level
  • BLFS $25.60
  • CRI $34.98
  • Average True Range (ATR)
  • BLFS 1.58
  • CRI 1.57
  • MACD
  • BLFS -0.07
  • CRI 0.18
  • Stochastic Oscillator
  • BLFS 48.32
  • CRI 29.37

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: